Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Fp-025
2. Fp025
3. Fp 025
4. Fp-003
5. Fp 003
6. Fp003
7. Inhibitor Of Mmp-12 Fp-025
8. Fp-025 (c21h18n2o4s)
1. 877176-23-3
2. Fp-025
3. Fp025
4. 2iz5925nzq
5. Refchem:915169
6. Inhibitor Of Mmp-12 Fp-025
7. Fp003
8. Fp 003
9. Fp 025
10. Fp-003
11. Fp-025 (c21h18n2o4s)
12. Aderamastat (usan/inn)
13. Aderamastat [usan]
14. Orb1941603
15. Schembl1832423
16. Chembl5314499
17. Glxc-27891
18. Hy-156963
19. Cs-0905149
20. D12909
21. H39097
22. 2,4-imidazolidinedione, 5-[3-[[4-[(3-methylphenyl)methoxy]phenyl]thio]-2-furanyl]-
23. 5-(3-((4-((3-methylbenzyl)oxy)phenyl)thio)furan-2-yl)imidazolidine-2,4-dione
| Molecular Weight | 394.4 g/mol |
|---|---|
| Molecular Formula | C21H18N2O4S |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 106 |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 567 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE